Neurocrine Biosciences (NBIX) Says FDA Panel to Review INGREZZA on 02/16/17, PDUFA set for 04/11/17
Go back to Neurocrine Biosciences (NBIX) Says FDA Panel to Review INGREZZA on 02/16/17, PDUFA set for 04/11/17| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 137.76 -1.21 (0.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $138.97 | 52 Week High | $58.46 | |||
| Open | $139.37 | 52 Week Low | $31.25 | |||
| Day High | $139.37 | P/E | N/A | |||
| Day Low | $136.06 | EPS | $-0.69 | |||
| Volume | 735,781 | |||||
